Electrolytic acid or alkaline water having a NMR half line width using 17 O of from about 45 to less than 51 Hz, and an oxide reduction potential of from -1000 to +200 mV, or from +600 to +1300 mV, topical compositions that contain such water, uses for such water to hydrate skin, deliver drugs and treat various skin and mucosal conditions, and methods and apparatus for manufacturing the water.